Protocol to request
Drug combination screening and validation
Research Article
Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment
Youyou Zhang et al.
DOI: 10.7554/eLife.99225